Literature DB >> 10433623

Evidence for the colonic origin of ovarian cancer cell line SW626.

M T Furlong1, C D Hough, C A Sherman-Baust, E S Pizer, P J Morin.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10433623     DOI: 10.1093/jnci/91.15.1327

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  9 in total

1.  Identification of epithelial ovarian tumor-specific aptamers.

Authors:  Gregory Benedetto; Timothy J Hamp; Peter J Wesselman; Christine Richardson
Journal:  Nucleic Acid Ther       Date:  2015-04-20       Impact factor: 5.486

2.  BRCA1/2 mutation analysis in 41 ovarian cell lines reveals only one functionally deleterious BRCA1 mutation.

Authors:  Britta Stordal; Kirsten Timms; Angela Farrelly; Danielle Gallagher; Steven Busschots; Mickaël Renaud; Julien Thery; Deborah Williams; Jennifer Potter; Thanh Tran; Greg Korpanty; Mattia Cremona; Mark Carey; Jie Li; Yang Li; Ozlem Aslan; John J O'Leary; Gordon B Mills; Bryan T Hennessy
Journal:  Mol Oncol       Date:  2013-01-31       Impact factor: 6.603

3.  DNA methylation profiles of ovarian epithelial carcinoma tumors and cell lines.

Authors:  Sahar Houshdaran; Sarah Hawley; Chana Palmer; Mihaela Campan; Mari N Olsen; Aviva P Ventura; Beatrice S Knudsen; Charles W Drescher; Nicole D Urban; Patrick O Brown; Peter W Laird
Journal:  PLoS One       Date:  2010-02-22       Impact factor: 3.240

4.  Secretion of soluble complement inhibitors factor H and factor H-like protein (FHL-1) by ovarian tumour cells.

Authors:  S Junnikkala; J Hakulinen; H Jarva; T Manuelian; L Bjørge; R Bützow; P F Zipfel; S Meri
Journal:  Br J Cancer       Date:  2002-11-04       Impact factor: 7.640

5.  Kallikrein family proteases KLK6 and KLK7 are potential early detection and diagnostic biomarkers for serous and papillary serous ovarian cancer subtypes.

Authors:  Ayala Tamir; Ushma Jag; Sreeja Sarojini; Craig Schindewolf; Takemi Tanaka; Rajendra Gharbaran; Hiren Patel; Anil Sood; Wei Hu; Ruzeen Patwa; Patrick Blake; Polina Chirina; Jin Oh Jeong; Heejin Lim; Andre Goy; Andrew Pecora; K Stephen Suh
Journal:  J Ovarian Res       Date:  2014-12-05       Impact factor: 4.234

6.  CircATRNL1 and circZNF608 Inhibit Ovarian Cancer by Sequestering miR-152-5p and Encoding Protein.

Authors:  Mengmeng Lyu; Xiujuan Li; Yang Shen; Jin Lu; Lihua Zhang; Shanliang Zhong; Jinhua Wang
Journal:  Front Genet       Date:  2022-02-23       Impact factor: 4.599

7.  Claudin-containing exosomes in the peripheral circulation of women with ovarian cancer.

Authors:  Jianghong Li; Cheryl A Sherman-Baust; Miyun Tsai-Turton; Robert E Bristow; Richard B Roden; Patrice J Morin
Journal:  BMC Cancer       Date:  2009-07-20       Impact factor: 4.430

8.  Organoruthenium Complexes with Benzo-Fused Pyrithiones Overcome Platinum Resistance in Ovarian Cancer Cells.

Authors:  Jerneja Kladnik; James P C Coverdale; Jakob Kljun; Hilke Burmeister; Petra Lippman; Francesca G Ellis; Alan M Jones; Ingo Ott; Isolda Romero-Canelón; Iztok Turel
Journal:  Cancers (Basel)       Date:  2021-05-20       Impact factor: 6.639

9.  Matching cell lines with cancer type and subtype of origin via mutational, epigenomic, and transcriptomic patterns.

Authors:  Marina Salvadores; Francisco Fuster-Tormo; Fran Supek
Journal:  Sci Adv       Date:  2020-07-01       Impact factor: 14.136

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.